Personal Home Page

http://www.mayoclinic.org/bio/10028391.html

Articles in Scholarly Journals [Incomplete List]

1. Editorial Comment on: Renal Angiomyolipoma: Long-term Results Following Selective Arterial Embolization
   European Urology, 2008
2. Reassessing the Diagnostic Yield of Saturation Biopsy of the Prostate
   European Urology, vol. 53, no. 5, pp. 976–983, 2008
3. Editorial Comment
   The Journal of Urology, vol. 179, no. 1, pp. 129–129, 2008
4. Re: Location of Extrarenal Tumor Extension Does Not Impact Survival of Patients With pT3a Renal Cell CarcinomaV. Margulis, P. Tamboli, S. F. Matin, M. Meisner, D. A. Swanson and C. G. Wood J Urol 2007; 178: 1878–1882
   The Journal of Urology, vol. 180, no. 1, pp. 409–410, 2008
5. Editorial Comment
   The Journal of Urology, vol. 179, no. 1, pp. 161–162, 2008
6. Differences in Organ System of Distant Metastasis by Renal Cell Carcinoma Subtype
   The Journal of Urology, vol. 179, no. 2, pp. 474–477, 2008
7. Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy
   The Journal of Urology, vol. 179, no. 2, pp. 468–473, 2008
8. Prostate Specific Antigen Kinetics in the Management of Prostate Cancer
   The Journal of Urology, vol. 179, no. 3, pp. 821–826, 2008
9. Analysis of Repeat Nephron Sparing Surgery as a Treatment Option in Patients With a Solid Mass in a Renal Remnant
   The Journal of Urology, vol. 179, no. 3, pp. 853–856, 2008
10. Radical Retropubic Prostatectomy in Immunosuppressed Transplant Recipients
    The Journal of Urology, vol. 179, no. 4, pp. 1349–1353, 2008
11. Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy
    The Journal of Urology, vol. 179, no. 4, pp. 1354–1361, 2008
12. Timing of Androgen Deprivation Therapy and its Impact on Survival After Radical Prostatectomy: A Matched Cohort Study
    The Journal of Urology, vol. 179, no. 5, pp. 1830–1837, 2008
13. Positive Surgical Margins at Partial Nephrectomy: Predictors and Oncological Outcomes
    The Journal of Urology, vol. 179, no. 6, pp. 2158–2163, 2008
14. Preoperative Nomogram Predicting 12-Year Probability of Metastatic Renal Cancer
    The Journal of Urology, vol. 179, no. 6, pp. 2146–2151, 2008
15. Pharmacoangiographic Evidence of the Presence and Anatomical Dominance of Accessory Pudendal Artery(s)
    The Journal of Urology, vol. 179, no. 6, pp. 2317–2320, 2008
16. Percutaneous Renal Cryoablation: Experience Treating 115 Tumors
    The Journal of Urology, vol. 179, no. 6, pp. 2136–2141, 2008
17. Surgical Resection of Isolated Retroperitoneal Lymph Node Recurrence of Renal Cell Carcinoma Following Nephrectomy
    The Journal of Urology, vol. 180, no. 1, pp. 99–103, 2008
18. Bladder Cancer Risk Following Primary and Adjuvant External Beam Radiation for Prostate Cancer
    The Journal of Urology, vol. 179, no. 5, pp. S7–S11, 2008
19. The Impact of Temporal Presentation on Clinical and Pathological Outcomes for Patients with Sporadic Bilateral Renal Masses
    European Urology, vol. 54, no. 4, pp. 855–865, 2008
20. Association of Abnormal Preoperative Laboratory Values with Survival After Radical Nephrectomy for Clinically Confined Clear Cell Renal Cell Carcinoma
    Urology, vol. 71, no. 2, pp. 278–282, 2008
21. Endoscopic Management of Upper Tract Transitional Cell Carcinoma in Patients with Normal Contralateral Kidneys
    Urology, 2008
22. Surgical Management, Complications, and Outcome of Radical Nephrectomy with Inferior Vena Cava Tumor Thrombectomy Facilitated by Vascular Bypass
    Urology, vol. 72, no. 1, pp. 148–152, 2008
23. 1. Microvascular tumor invasion in renal cell carcinoma: The most important prognostic factorDall’Oglio MF, Antunes AA, Sarkis AS, Crippa A, Leite KR, Lucon AM, Srougi M, Division of Urology, University of Sao Paulo Medical School, Sao Paulo, Brazil
    Urologic Oncology: Seminars and Original Investigations, vol. 26, no. 1, pp. 98–99, 2008
24. 1. Redefining pT3 renal cell carcinoma in the modern era: A proposal for a revision of the current TNM primary tumor classification systemMargulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG, Department of Urology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX
    Urologic Oncology: Seminars and Original Investigations, vol. 26, no. 1, pp. 99–100, 2008
25. Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experienceKlatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galetti T, Allhoff EP, Schips L, Zigeuner R, Figlin RA, Kabbinavar FF, Pantuck AJ, Belldegrun AS, Lam JS, Department of Urology, University of California, Los Angeles, CA, and Centre Hospitalier Universitaire Pontchaillou, Rennes, France
    Urologic Oncology: Seminars and Original Investigations, vol. 26, no. 1, pp. 100–101, 2008
26. A prospective randomized EORTC intergroup Phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinomaVan Poppel H, Da Pozzo L, Albrecht W, Matveev V, Bono A, Borkowski A, Marechal JM, Klotz L, Skinner E, Keane T, Claessens I, Sylvester R, European Organization for Research and Treatment of Cancer (EORTC); National Cancer Institute of Canada Clinical Trials Group (NCIC CTG); Southwest Oncology Group (SWOG); Eastern Cooperative Oncology Group (ECOG). Department of Urology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium
    Urologic Oncology: Seminars and Original Investigations, vol. 26, no. 1, pp. 101–102, 2008
27. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumorsStern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI, Cadeddu JA, Department of Urology, University of Texas, Southwestern Medical Center, Dallas, TX
    Urologic Oncology: Seminars and Original Investigations, vol. 26, no. 1, pp. 102–102, 2008
28. Surgery Insight: management of renal cell carcinoma with associated inferior vena cava thrombus
    Nature Clinical Practice Urology, Article ID ncpuro1122, 2008
29. Multifocal Renal Cell Carcinoma: Clinicopathologic Features and Outcomes for Tumors ≤4 cm
    Advances in Urology, vol. 2008, Article ID 518091, 7 pages, 2008
30. Primary Retroperitoneal Lipoma: A Soft Tissue Pathology Heresy?
    The American Journal of Surgical Pathology, vol. 32, no. 6, pp. 951–954, 2008
31. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma
    International Journal of Urology, vol. 15, no. 4, pp. 304–308, 2008
32. How long is too long? The effect of the duration of anaesthesia on the incidence of non-urological complications after surgery
    BJU International, vol. 102, no. 3, pp. 301–304, 2008
33. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery
    BJU International, vol. 101, no. 11, pp. 1375–1379, 2008
34. Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
    Cancer Research, vol. 68, no. 15, pp. 6054–6058, 2008
35. Radical Prostatectomy by Open or Laparoscopic/Robotic Techniques: An Issue of Surgical Device or Surgical Expertise?
    Journal of Clinical Oncology, vol. 26, no. 14, pp. 2248–2249, 2008
36. Tumor-Infiltrating Foxp3-CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma
    Clinical Cancer Research, vol. 13, no. 7, pp. 2075–2081, 2007
37. PD-1 Is Expressed by Tumor-Infiltrating Immune Cells and Is Associated with Poor Outcome for Patients with Renal Cell Carcinoma
    Clinical Cancer Research, vol. 13, no. 6, pp. 1757–1761, 2007
38. Two Common Chromosome 8q24 Variants Are Associated with Increased Risk for Prostate Cancer
    Cancer Research, vol. 67, no. 7, pp. 2944–2950, 2007
39. B7-H3 Ligand Expression by Prostate Cancer: A Novel Marker of Prognosis and Potential Target for Therapy
    Cancer Research, vol. 67, no. 16, pp. 7893–7900, 2007
40. Evaluation of Genetic Variations in the Androgen and Estrogen Metabolic Pathways as Risk Factors for Sporadic and Familial Prostate Cancer
    Cancer Epidemiology Biomarkers & Prevention, vol. 16, no. 5, pp. 969–978, 2007
41. Survivin and B7-H1 Are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma
    Clinical Cancer Research, vol. 13, no. 6, pp. 1749–1756, 2007
42. Renal cell carcinoma: vena caval involvement
    BJU International, vol. 99, no. 5b, pp. 1239–1244, 2007
43. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8–10 cancers
    BJU International, vol. 0, no. 0, pp. 071008065132002–???, 2007
44. Patients With pT1 Renal Cell Carcinoma Who Die From Disease After Nephrectomy May Have Unrecognized Renal Sinus Fat Invasion
    The American Journal of Surgical Pathology, vol. 31, no. 7, pp. 1089–1093, 2007
45. Nephron-sparing surgery: the 'gold standard' treatment for small renal cortical tumors
    Nature Clinical Practice Urology, vol. 4, no. 6, Article ID ncpuro0763, 1 pages, 2007
46. Potential Underdetection of pT3a Renal-Cell Carcinoma with Laparoscopic Morcellation
    Journal of Endourology, vol. 21, no. 10, pp. 1183–1186, 2007
47. Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma☆
    Human Pathology, vol. 38, no. 3, pp. 453–461, 2007
48. Treatment of Prostate Cancer Local Recurrence After Radical Retropubic Prostatectomy with 17-Gauge Interstitial Transperineal Cryoablation: Initial Experience
    Urology, vol. 70, no. 1, pp. 80–85, 2007
49. Surgical Resection Provides Excellent Outcomes for Patients With Cystic Clear Cell Renal Cell Carcinoma
    Urology, vol. 70, no. 5, pp. 900–904, 2007
50. Impact of Tumor Size on the Predictive Ability of the pT3a Primary Tumor Classification for Renal Cell Carcinoma
    The Journal of Urology, vol. 177, no. 1, pp. 59–62, 2007
51. The Impact of Ischemia Time During Open Nephron Sparing Surgery on Solitary Kidneys: A Multi-Institutional Study
    The Journal of Urology, vol. 177, no. 2, pp. 471–476, 2007
52. Dynamic Outcome Prediction in Patients With Clear Cell Renal Cell Carcinoma Treated With Radical Nephrectomy: The D-SSIGN Score
    The Journal of Urology, vol. 177, no. 2, pp. 477–480, 2007
53. Endoscopic Management of Upper Tract Urothelial Carcinoma in Patients With a History of Bladder Urothelial Carcinoma
    The Journal of Urology, vol. 177, no. 5, pp. 1721–1726, 2007
54. Results of Inferior Vena Caval Interruption by Greenfield Filter, Ligation or Resection During Radical Nephrectomy and Tumor Thrombectomy
    The Journal of Urology, vol. 178, no. 2, pp. 440–445, 2007
55. Is the GPSM Scoring Algorithm for Patients With Prostate Cancer Valid in the Contemporary Era?
    The Journal of Urology, vol. 178, no. 2, pp. 459–463, 2007
56. Imperative Indications for Conservative Management of Upper Tract Transitional Cell Carcinoma
    The Journal of Urology, vol. 178, no. 3, pp. 792–797, 2007
57. The Role of Partial Nephrectomy for the Management of Sporadic Renal Angiomyolipoma
    Urology, vol. 70, no. 6, pp. 1064–1068, 2007
58. Long-Term Outcome After Radical Prostatectomy for Patients With Lymph Node Positive Prostate Cancer in the Prostate Specific Antigen Era
    The Journal of Urology, vol. 178, no. 3, pp. 864–871, 2007
59. At What Point Does Warm Ischemia Cause Permanent Renal Damage during Partial Nephrectomy?
    European Urology, vol. 52, no. 4, pp. 961–963, 2007
60. Critical comparison of laparoscopic, robotic, and open radical prostatectomy: Techniques, outcomes, and cost
    Current Prostate Reports, vol. 5, no. 2, pp. 61–67, 2007
61. Preventing pain during office biopsy of the prostate
    Cancer, vol. 110, no. 8, pp. 1708–1714, 2007
62. Comparison of 1,800 Laparoscopic and Open Partial Nephrectomies for Single Renal Tumors
    The Journal of Urology, vol. 178, no. 1, pp. 41–46, 2007
63. The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma
    Cancer, vol. 106, no. 2, pp. 304–312, 2006
64. Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival
    Cancer, vol. 107, no. 1, pp. 46–53, 2006
65. Urachal carcinoma: Clinicopathologic features and long-term outcomes of an aggressive malignancy
    Cancer, vol. 107, no. 4, pp. 712–720, 2006
66. Obesity and survival after radical prostatectomy: A 10-year prospective cohort study
    Cancer, vol. 107, no. 3, pp. 521–529, 2006
67. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma
    Cancer, vol. 107, no. 1, pp. 37–45, 2006
68. Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001
    Cancer, vol. 106, no. 12, pp. 2630–2635, 2006
69. Critical comparison of laparoscopic, robotic, and open radical prostatectomy: techniques, outcomes, and cost
    Current Urology Reports, vol. 7, no. 3, pp. 193–199, 2006
70. Impact of Familial and Hereditary Prostate Cancer on Cancer Specific Survival After Radical Retropubic Prostatectomy
    The Journal of Urology, vol. 176, no. 3, pp. 1118–1121, 2006
71. Second Primary Malignancies Associated With Renal Cell Carcinoma Histological Subtypes
    The Journal of Urology, vol. 176, no. 3, pp. 900–904, 2006
72. The Role of Nephron Sparing Surgery for Metastatic (pM1) Renal Cell Carcinoma
    The Journal of Urology, vol. 176, no. 5, pp. 1990–1995, 2006
73. Extranodal Extension in Regional Lymph Nodes is Associated With Outcome in Patients With Renal Cell Carcinoma
    The Journal of Urology, vol. 176, no. 5, pp. 1978–1983, 2006
74. Clinical sequelae of radiographic iceball involvement of collecting system during computed tomography-guided percutaneous renal tumor cryoablationWarlick CA, Lima GC, Allaf ME, Varkarakis I, Permpongkosol S, Schaeffer EM, Kavoussi LR, Jarrett TW, Solomon SB, James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 6, pp. 554–554, 2006
75. Detectable Prostate Specific Antigen Between 60 and 120 Days Following Radical Prostatectomy for Prostate Cancer: Natural History and Prognostic Significance
    The Journal of Urology, vol. 176, no. 2, pp. 559–563, 2006
76. Simple graphic method for estimation of prostate-specific antigen doubling time
    Urology, vol. 67, no. 2, pp. 408–409, 2006
77. The diagnosis and staging of bladder cancer: From RBCs to TURs
    Urology, vol. 67, no. 3, pp. 3–8, 2006
78. The use of urine-based biomarkers in bladder cancer
    Urology, vol. 67, no. 3, pp. 62–64, 2006
79. The management of superficial transitional cell carcinoma of the bladder
    Urology, vol. 67, no. 3, pp. 48–54, 2006
80. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy
    Urology, vol. 68, no. 1, pp. 94–98, 2006
81. Outcomes of gleason score 10 prostate carcinoma treated by radical prostatectomy
    Urology, vol. 68, no. 3, pp. 604–608, 2006
82. Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma
    Urology, vol. 68, no. 4, pp. 741–746, 2006
83. Surgical Management of Renal Cell Carcinoma
    Seminars in Oncology, vol. 33, no. 5, pp. 552–562, 2006
84. B7-H4 expression in renal cell carcinoma and tumor vasculature: Associations with cancer progression and survival
    Proceedings of the National Academy of Sciences, vol. 103, no. 27, pp. 10391–10396, 2006
85. The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancerLamb GW, McMillan DC, Ramsey S, Aitchison M, Department of Urology, Gartnavel General Hospital, Glasgow, United Kingdom
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 6, pp. 555–556, 2006
86. Open partial nephrectomy for tumor in a solitary kidney: Experience with 400 casesFergany AF, Saad IR, Woo L, Novick AC, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 6, pp. 556–556, 2006
87. Comparison of outcomes in elective partial vs radical nephrectomy for clear cell renal cell carcinoma of 4–7 cmDash A, Vickers AJ, Schachter LR, Bach AM, Snyder ME, Russo P, Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 6, pp. 557–557, 2006
88. Editorial comment
    The Journal of Urology, vol. 175, no. 5, pp. 1667–1667, 2006
89. Rare Expression of KIT and Absence of KIT Mutations in High Grade Renal Cell Carcinoma
    The Journal of Urology, vol. 175, no. 1, pp. 53–56, 2006
90. Long-Term Prognostic Significance of Primary Gleason Pattern in Patients With Gleason Score 7 Prostate Cancer: Impact on Prostate Cancer Specific Survival
    The Journal of Urology, vol. 175, no. 2, pp. 547–551, 2006
91. Impact of Patient Age at Treatment on Outcome Following Radical Retropubic Prostatectomy for Prostate Cancer
    The Journal of Urology, vol. 175, no. 3, pp. 952–957, 2006
92. Increasing Prostate Specific Antigen Following Radical Prostatectomy and Adjuvant Hormonal Therapy: Doubling Time Predicts Survival
    The Journal of Urology, vol. 175, no. 5, pp. 1684–1690, 2006
93. Sunitinib in patients with metastatic renal cell carcinomaMotzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 6, pp. 553–554, 2006
94. Fibrin sealant for retrograde ureteroscopic closure of urine leak after partial nephrectomyFrench DB, Marcovich R, Department of Urology, University of Texas Health Science Center, San Antonio, TX
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 6, pp. 554–555, 2006
95. Intermediate results of laparoscopic cryoablation in 59 patients at the Medical College of WisconsinLawatsch EJ, Langenstroer P, Byrd GF, See WA, Quiroz FA, Begun FP, Departments of Urology and Radiology, Medical College of Wisconsin, Milwaukee, WI
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 6, pp. 555–555, 2006
96. Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinomaBuchner A, Riesenberg R, Kotter I, Hofstetter A, Stief C, Oberneder R, Department of Urology, Klinikum Groshadern, Ludwig-Maximilians-University, Munich, Germany
    Urologic Oncology: Seminars and Original Investigations, vol. 24, no. 6, pp. 557–558, 2006
97. Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up
    Cancer Research, vol. 66, no. 7, pp. 3381–3385, 2006
98. Can the kidney function as a lung? Systemic oxygenation and renal preservation during retrograde perfusion of the ischaemic kidney in rabbits
    BJU International, vol. 98, no. 3, pp. 674–679, 2006
99. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome
    BJU International, vol. 95, no. 6, pp. 751–756, 2005
100. Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series
     BJU International, vol. 96, no. 1, pp. 54–57, 2005
101. Clear Cell Renal Cell Carcinoma: Gene Expression Analyses Identify a Potential Signature for Tumor Aggressiveness
     Clinical Cancer Research, vol. 11, no. 14, pp. 5128–5139, 2005
102. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvementFrank I, Cheville JC, Blute ML, Lohse CM, Karnes RJ, Weaver AL, Sebo TJ, Nehra A, Zincke H, Department of Urology, Mayo Clinic, Rochester, MN
     Urologic Oncology: Seminars and Original Investigations, vol. 23, no. 3, pp. 221–222, 2005
103. A SCORING ALGORITHM TO PREDICT SURVIVAL FOR PATIENTS WITH METASTATIC CLEAR CELL RENAL CELL CARCINOMA: A STRATIFICATION TOOL FOR PROSPECTIVE CLINICAL TRIALS
     The Journal of Urology, vol. 174, no. 5, pp. 1759–1763, 2005
104. RE: THE ACCURACY OF 250 FINE NEEDLE BIOPSIES OF RENAL TUMORS
     The Journal of Urology, vol. 174, no. 6, pp. 2422–2422, 2005
105. PREOPERATIVE PROSTATE SPECIFIC ANTIGEN DOUBLING TIME AND VELOCITY ARE STRONG AND INDEPENDENT PREDICTORS OF OUTCOMES FOLLOWING RADICAL PROSTATECTOMY
     The Journal of Urology, vol. 174, no. 6, pp. 2191–2196, 2005
106. ASSOCIATIONS WITH CONTRALATERAL RECURRENCE FOLLOWING NEPHRECTOMY FOR RENAL CELL CARCINOMA USING A COHORT OF 2,352 PATIENTS
     The Journal of Urology, vol. 173, no. 2, pp. 391–394, 2005
107. MONITORING INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER USING FLUORESCENCE IN SITU HYBRIDIZATION
     The Journal of Urology, vol. 173, no. 2, pp. 401–404, 2005
108. pT2 CLASSIFICATION FOR RENAL CELL CARCINOMA. CAN ITS ACCURACY BE IMPROVED?
     The Journal of Urology, vol. 173, no. 2, pp. 380–384, 2005
109. CANCER SPECIFIC SURVIVAL FOR PATIENTS WITH pT3 RENAL CELL CARCINOMA—CAN THE 2002 PRIMARY TUMOR CLASSIFICATION BE IMPROVED?
     The Journal of Urology, vol. 173, no. 3, pp. 716–719, 2005
110. THE EXTENT OF LYMPHADENECTOMY FOR pTXNO PROSTATE CANCER DOES NOT AFFECT PROSTATE CANCER OUTCOME IN THE PROSTATE SPECIFIC ANTIGEN ERA
     The Journal of Urology, vol. 173, no. 4, pp. 1121–1125, 2005
111. URINARY FISTULAS FOLLOWING EXTERNAL RADIATION OR PERMANENT BRACHYTHERAPY FOR THE TREATMENT OF PROSTATE CANCER
     The Journal of Urology, vol. 173, no. 6, pp. 1953–1957, 2005
112. INDEPENDENT VALIDATION OF THE 2002 AMERICAN JOINT COMMITTEE ON CANCER PRIMARY TUMOR CLASSIFICATION FOR RENAL CELL CARCINOMA USING A LARGE, SINGLE INSTITUTION COHORT
     The Journal of Urology, vol. 173, no. 6, pp. 1889–1892, 2005
113. COMPARISON OF PRESENTATION AND OUTCOME FOR PATIENTS 18 TO 40 AND 60 TO 70 YEARS OLD WITH SOLID RENAL MASSES
     The Journal of Urology, vol. 173, no. 6, pp. 1893–1896, 2005
114. BLADDER CANCER RISK FOLLOWING PRIMARY AND ADJUVANT EXTERNAL BEAM RADIATION FOR PROSTATE CANCER
     The Journal of Urology, vol. 174, no. 1, pp. 107–110, 2005